The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

The first UK patient has been dosed with a personalised [...]

Kairos Pharma and Bayer will evaluate ENV-105 in combination with [...]

Kairos Pharma has reported positive interim safety results from an [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

Evogene Ltd has partnered with Queensland University of Technology to [...]

Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]

Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]

  The National Institute for Health and Care Excellence has [...]

N4 Pharma has reported new data from its collaboration with [...]